CanSino Biologics Inc. 康希諾生物股份公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：6185） 自願公告 獲 得PIC/S GMP認 證 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部 或任何部分內容所產生或因依賴該等內容而引致的任何損失承擔任何責任。 本次通過PIC/S GMP認 證，標 誌 著 本 公 司 的 生 產 和 質 量 管 理 體 系 符 合PIC/S GMP 的標準，將有助於推進MCV4、PCV13 i 在馬來西亞及其他PIC/S成員國藥品註冊上 市的工作。 本公司股東及潛在投資者在買賣本公司股份時務請審慎行事。 承董事會命 康希諾生物股份公司 Xuefeng YU 董事長 香港，2026年3月5日 於本公告日期，本公司董事會包括執行董事Xuefeng YU博士、Shou Bai CHAO博 士 及王靖女士；非執行董事李志成先生；以及獨立非執行董事張耀樑先生、左敏先 生及紀雪峰女士。 本 公 告 由 康 希 諾 生 物 股 份 公 司（「本公司」）自 願 作 出。 ...

Macro Dynamics - In the first five months of 2025, China attracted foreign investment amounting to 358.19 billion RMB, a year-on-year decrease of 13.2% [1] - The number of newly established foreign-invested enterprises reached 24,018, marking a 10.4% increase year-on-year [1] - High-tech industries saw a significant increase in foreign investment, with e-commerce services up 146%, aerospace manufacturing up 74.9%, chemical pharmaceuticals up 59.2%, and medical equipment manufacturing up 20% [1] - Investment from ASEAN countries grew by 20.5%, while Japan, the UK, South Korea, and Germany saw increases of 70.2%, 60.9%, 10.3%, and 7.1% respectively [1] Financial Data - From January to May, the total stamp duty on securities transactions reached 66.8 billion RMB, a 52.4% increase year-on-year [2] - The overall stamp duty collected during the same period was 178.7 billion RMB, reflecting an 18.8% year-on-year growth [2] Industry Policies - The "old-for-new" subsidy policy for consumer goods will continue, with central funds being allocated in batches throughout the year [3] - A total of 300 billion RMB in national bond funds will be directed to support local governments in implementing the "old-for-new" policy [3] Energy Consumption - In May, China's total electricity consumption reached 809.6 billion kWh, a year-on-year increase of 4.4% [5] - Cumulative electricity consumption from January to May was 39,665 billion kWh, reflecting a 3.4% year-on-year growth [5] Company Dynamics - Ele.me's logistics head has been investigated for alleged job-related crimes, with the company cooperating with law enforcement [11] - Huizhou Yuantong was fined 24.31 million RMB by the People's Bank of China for multiple regulatory violations [13] - CanSino Biologics received a drug registration certificate for its 13-valent pneumococcal polysaccharide conjugate vaccine [14] - Zhang Xiaoqin's controlling shareholder has entered restructuring proceedings as approved by the local court [15] - Douyin has initiated a special action to combat corporate defamation and protect the rights of businesses and entrepreneurs [16] - Hainan Huatie clarified that it is not involved in stablecoin business and has no formal agreements with Ant Group regarding RWA [18]